Numerous pre- and post-treatment nomograms based on well-established clinicopathological factors, such as clinical and pathological tumor stage, bioptic and pathological histological grading systems according to Gleason, and PSA values, have been used to estimate the individual risk of the disease course. This evidence concerns the gene KLK3 and neoplasm.